SV2C and Parkinson disease: In more recent investigations, cutting-edge single-nuclei RNA sequencing analysis on post-mortem substantia nigra from PD patients and healthy controls has revealed a subpopulation of dopaminergic neurons exhibiting a 0.5-fold decrease in SV2C expression in the PD cases (Wang et al., 2024).